EP1928903
Frumugagndræpir peptíðlatar JNK boðmiðlunartaugabrautar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.9.2006EP published:
30.5.2012EP application number:
06792004.1
EP translation filed:
2.7.2012Grant published:
15.7.2012EPO information:
European Patent Register
Max expiry date:
11.9.2026Expiry date:
11.9.2019
Title:
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY
Timeline
Today
12.9.2006EP application
30.5.2012EP Publication
2.7.2012Translation submitted
15.7.2012Registration published
11.9.2019Expires
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III, 195 Neocleous House, 3030, Limassol, CY
Inventor
Name:
BONNY, ChristopheAddress:
Lausanne, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2005/009782Date:
12.9.2005Country:
WO
Classification
Categories:
C07K 14/47
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.9.2012
Expires: 11.9.2013
Payer: Guðjón Styrkársson, hrl.
Number: 8
Paid: 24.9.2013
Expires: 11.9.2014
Payer: Guðjón Styrkársson, hrl.
Number: 9
Paid: 18.9.2014
Expires: 11.9.2015
Payer: Guðjón Styrkársson, hrl.
Number: 10
Paid: 17.9.2015
Expires: 11.9.2016
Payer: Guðjón Styrkársson, hrl.
Number: 11
Paid: 20.9.2016
Expires: 11.9.2017
Payer: Guðjón Styrkársson, hrl.
Number: 12
Paid: 28.9.2017
Expires: 11.9.2018
Payer: Guðjón Styrkársson, hrl.
Number: 13
Paid: 15.2.2019
Expires: 11.9.2019
Payer: Guðjón Styrkársson, hrl.